Compare XBIT & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | AKA |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | United States | United States |
| Employees | 87 | N/A |
| Industry | Pharmaceuticals and Biotechnology | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.8M | 105.4M |
| IPO Year | 2015 | 2021 |
| Metric | XBIT | AKA |
|---|---|---|
| Price | $2.20 | $10.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $24.33 |
| AVG Volume (30 Days) | ★ 45.9K | 2.1K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $600,208,000.00 |
| Revenue This Year | N/A | $6.14 |
| Revenue Next Year | N/A | $4.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.44 |
| 52 Week Low | $2.09 | $8.42 |
| 52 Week High | $3.44 | $16.38 |
| Indicator | XBIT | AKA |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 49.68 |
| Support Level | $2.19 | $10.35 |
| Resistance Level | $2.46 | $11.69 |
| Average True Range (ATR) | 0.05 | 0.44 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 29.53 | 39.87 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.